1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
At least one recognised startup in every State and UT; spread across over 80% of districts
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
An accomplished R&D leader and champion of the application of AI to drug discovery
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Subscribe To Our Newsletter & Stay Updated